| Entry |
|
|---|
| Name |
Nitric oxide;
NO;
Nitrogen monoxide
|
|---|
| Formula |
NO
|
|---|
| Exact mass |
29.998
|
|---|
| Mol weight |
30.0061
|
|---|
| Structure |
   |
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00330 | Arginine and proline metabolism |
| map01120 | Microbial metabolism in diverse environments |
| map04270 | Vascular smooth muscle contraction |
| map04621 | NOD-like receptor signaling pathway |
| map05014 | Amyotrophic lateral sclerosis (ALS) |
| map05142 | Chagas disease (American trypanosomiasis) |
| map05418 | Fluid shear stress and atherosclerosis |
|
|---|
| Module |
| M00529 | Denitrification, nitrate => nitrogen |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R07 OTHER RESPIRATORY SYSTEM PRODUCTS
R07A OTHER RESPIRATORY SYSTEM PRODUCTS
R07AX Other respiratory system products
R07AX01 Nitric oxide
D00074 Nitric oxide (JAN/USAN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D00074 Nitric oxide (JAN/USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00074
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00074
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00074
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00074
 |
|---|
| Other DBs |
|
|---|
| LinkDB |
 |
|---|
| KCF data |
ATOM 2
1 O3a O 21.4046 -16.1648
2 N2a N 22.8046 -16.1648 #^
BOND 1
1 1 2 2
|
|---|
